Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marina Keil
Institution:
Merck Healthcare KGaA, Darmstadt (Germany)
Observed institutions:
Merck KGaA, Darmstadt (Germany),
Universität Ulm,
Merck Healthcare KGaA, Darmstadt (Germany),
Ruhr University Bochum
ORCID:
0009-0004-1799-2912
Observed ORCID:
0009-0004-1799-2912
OpenAlex ID:
A5014795699
The Wnt Target Protein Peter Pan Defines a Novel p53-independent Nucleolar Stress-Response Pathway
2015
·
Astrid S. Pfister
, Marina Keil
, et al.
·
Journal of Biological Chemistry
·
57
PDF
The Wnt/β-Catenin Pathway is Activated as a Novel Nucleolar Stress Response
2020
·
David P. Dannheisig
, Jana Bächle
, et al.
·
Journal of Molecular Biology
·
37
PDF
SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations
2020
·
Linda Pudelko
, Frank Jaehrling
, et al.
·
iScience
·
23
PDF
Loss of Peter Pan protein is associated with cell cycle defects and apoptotic events
2019
·
Marina Keil
, Maria T. Meyer
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
21
MoA Studies of the TEAD P-Site Binding Ligand MSC-4106 and Its Optimization to TEAD1-Selective Amide M3686
2024
·
Timo Heinrich
, Daniel Schwarz
, et al.
·
Journal of Medicinal Chemistry
·
12
Peroxisomal Import Reduces the Proapoptotic Activity of Deubiquitinating Enzyme USP2
2015
·
Katharina Reglinski
, Marina Keil
, et al.
·
PLoS ONE
·
11
PDF
Phenotypic Hit Identification and Optimization of Novel Pan-TEAD and Subtype-Selective Inhibitors
2025
·
Timo Heinrich
, Alessia Gambardella
, et al.
·
Journal of Medicinal Chemistry
·
8
Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2023
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
·
Molecular Cancer Therapeutics
·
4
PDF
Abstract 3774: Unraveling mechanisms of resistance to tepotinib and future treatment options
2020
·
Linda Pudelko
, Frank Jaehrling
, et al.
·
Cancer Research
·
1
Characterization of human Peter Pan in cell cycle and apoptosis
2019
·
Marina Keil
·
1
Supplementary Figure S11-4 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Figure S5-2 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Figure S6-2 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Table S7-2 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Table S4-1 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Table S6-1 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Table S10-1 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Table S3-1 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Figure S8-3 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Table S10-1 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Table S9-1 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Figure S8-2 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary methods S2 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary Table S7-1 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Supplementary methods S6 from Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models
2024
·
Manja Friese-Hamim
, Maria J. Ortiz Ruiz
, et al.
Show more works
View as search
Works count:
55
Citation count:
175
H-index:
7
I10-index:
6
Year
Topic
Type